These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16670526)

  • 1. CXC chemokine receptor 3 expression increases the disease-inducing potential of CD4+ CD25- T cells in adoptive transfer colitis.
    Kristensen NN; Gad M; Thomsen AR; Lu B; Gerard C; Claesson MH
    Inflamm Bowel Dis; 2006 May; 12(5):374-81. PubMed ID: 16670526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice.
    Takahara M; Nemoto Y; Oshima S; Matsuzawa Y; Kanai T; Okamoto R; Tsuchiya K; Nakamura T; Yamamoto K; Watanabe M
    Immunol Lett; 2013; 156(1-2):82-93. PubMed ID: 24070768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteroantigen-presenting B cells efficiently stimulate CD4(+) T cells in vitro.
    Schmidt EG; Kristensen NN; Claesson MH; Pedersen AE
    Inflamm Bowel Dis; 2011 Jan; 17(1):308-18. PubMed ID: 20722062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of T-regulatory cells, induced by immature dendritic cells, which inhibit enteroantigen-reactive colitis-inducing T-cell responses in vitro and in vivo.
    Gad M; Kristensen NN; Kury E; Claesson MH
    Immunology; 2004 Dec; 113(4):499-508. PubMed ID: 15554928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
    Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines involved in protection from colitis by CD4+CD25+ regulatory T cells.
    Kristensen NN; Brudzewsky D; Gad M; Claesson MH
    Inflamm Bowel Dis; 2006 Jul; 12(7):612-8. PubMed ID: 16804399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis
    Liu QZ; Ma WT; Yang JB; Zhao ZB; Yan K; Yao Y; Li L; Miao Q; Gershwin ME; Lian ZX
    Front Immunol; 2018; 9():1090. PubMed ID: 29868034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4 exacerbates disease in a Th1 cell transfer model of colitis.
    Fort M; Lesley R; Davidson N; Menon S; Brombacher F; Leach M; Rennick D
    J Immunol; 2001 Feb; 166(4):2793-800. PubMed ID: 11160346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice.
    Yamada Y; Okubo Y; Shimada A; Oikawa Y; Yamada S; Narumi S; Matsushima K; Itoh H
    Diabetologia; 2012 Aug; 55(8):2238-45. PubMed ID: 22487925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis.
    Strauch UG; Obermeier F; Grunwald N; Gürster S; Dunger N; Schultz M; Griese DP; Mähler M; Schölmerich J; Rath HC
    Gut; 2005 Nov; 54(11):1546-52. PubMed ID: 15987795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemokine receptor CXCR3 attenuates the control of chronic Mycobacterium tuberculosis infection in BALB/c mice.
    Chakravarty SD; Xu J; Lu B; Gerard C; Flynn J; Chan J
    J Immunol; 2007 Feb; 178(3):1723-35. PubMed ID: 17237422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
    Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):176-89. PubMed ID: 17241870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
    Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M
    Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Akiba H; Okumura K; Yagita H; Watanabe M
    J Immunol; 2009 May; 182(10):6079-87. PubMed ID: 19414759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor CXCR3 expression in inflammatory bowel disease.
    Yuan YH; ten Hove T; The FO; Slors JF; van Deventer SJ; te Velde AA
    Inflamm Bowel Dis; 2001 Nov; 7(4):281-6. PubMed ID: 11720316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of the chemokine receptor CXCR3 on lymphocytes from normal and inflammatory bowel disease mucosa.
    Papadakis KA; Prehn J; Zhu D; Landers C; Gaiennie J; Fleshner PR; Targan SR
    Inflamm Bowel Dis; 2004 Nov; 10(6):778-88. PubMed ID: 15626897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma-inducible chemokines enhance adaptive immunity and colitis.
    Singh UP; Singh S; Iqbal N; Weaver CT; McGhee JR; Lillard JW
    J Interferon Cytokine Res; 2003 Oct; 23(10):591-600. PubMed ID: 14585199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerogenic dendritic cells pulsed with enterobacterial extract suppress development of colitis in the severe combined immunodeficiency transfer model.
    Pedersen AE; Gad M; Kristensen NN; Haase C; Nielsen CH; Claesson MH
    Immunology; 2007 Aug; 121(4):526-32. PubMed ID: 17428312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance.
    Molesworth-Kenyon S; Mates A; Yin R; Strieter R; Oakes J; Lausch R
    Virology; 2005 Mar; 333(1):1-9. PubMed ID: 15708587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting memory T cell responses to TB: concerns using adoptive transfer into immunodeficient mice.
    Ancelet L; Rich FJ; Delahunt B; Kirman JR
    Tuberculosis (Edinb); 2012 Sep; 92(5):422-33. PubMed ID: 22738879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.